{"result": {"id": "chatcmpl-427", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Community Health & Vascular Research\",\n    \"summary\": \"This report analyzes the interconnected entities within a community focused on health and vascular research, highlighting their roles, relationships, and impact. The community comprises researchers, healthcare providers, patients, and organizations dedicated to advancing knowledge and treatment for cardiovascular diseases. Key insights reveal the community's structure, its focus on specific conditions like peripheral artery disease (PAD), and the potential for collaborative efforts in developing new treatments.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The community exhibits a high level of impact due to its direct involvement in addressing critical health issues. The research and treatment efforts have significant implications for patient well-being and public health.\",\n    \"findings\": [\n        {\n            \"summary\": \"Focus on Vascular Diseases: The community's core focus is on vascular diseases, particularly PAD, a prevalent condition affecting millions worldwide. Research efforts are directed towards understanding the underlying causes of PAD and developing effective treatment strategies.\",\n            \"explanation\": \"The community comprises researchers, clinicians, and healthcare professionals who specialize in vascular health. Their collective expertise allows them to conduct comprehensive research on PAD, including its prevalence, risk factors, and potential treatments. This focus on vascular diseases highlights the community's commitment to improving patient outcomes and addressing a significant public health concern.\"\n        },\n        {\n            \"summary\": \"Research & Development: The community actively engages in research and development of new therapies for vascular diseases. These efforts include clinical trials, pre-clinical studies, and collaborations with pharmaceutical companies.\",\n            \"explanation\": \"The community's commitment to innovation is evident through its active involvement in research and development. Researchers are constantly exploring novel treatment options for PAD, including gene therapy, stem cell therapy, and targeted drug delivery systems. These efforts aim to develop more effective and personalized treatments that improve patient outcomes.\"\n        },\n        {\n            \"summary\": \"Collaboration & Partnerships: The community fosters collaboration between researchers, healthcare providers, and patients through partnerships with academic institutions, hospitals, and non-profit organizations.\",\n            \"explanation\": \"The community's collaborative nature is crucial for its success. By partnering with various stakeholders, the community can leverage diverse expertise and resources to accelerate research progress and translate findings into real-world applications. These collaborations ensure that research efforts are aligned with patient needs and societal impact.\"\n        },\n        {\n            \"summary\": \"Impact on Patient Care: The community's work directly impacts patients by improving their access to quality care, developing new treatment options, and promoting public health initiatives.\",\n            \"explanation\": \"The community's research and development efforts translate into tangible benefits for patients. New treatments developed through the community's research can improve PAD management, reduce complications, and enhance patient quality of life. Additionally, the community plays a vital role in educating the public about vascular diseases, promoting healthy lifestyle choices, and advocating for policy changes that support cardiovascular health.\"\n        },\n        {\n            \"summary\": \"Community Engagement: The community actively engages with patients and communities through outreach programs, educational initiatives, and patient support groups.\",\n            \"explanation\": \"The community recognizes the importance of patient engagement in its mission. By connecting with patients directly, the community can address their concerns, provide personalized guidance, and foster a sense of empowerment. This approach ensures that research efforts are aligned with patient needs and priorities.\"\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743161721, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 714, "prompt_tokens": 2048, "total_tokens": 2762, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n1105,BROLUCIZUMAB,\"Brolucizumab is a drug currently under study for treating certain eye conditions. It is also being investigated as a potential treatment for inflammation in the eye, specifically for conditions like neovascular age-related macular degeneration (nAMD).  This medication is often referred to as IB and has been used to treat central serous retinopathy (CSR) secondary to autoimmune diseases such as uveitis or ankylosing spondylitis. \n\",3\n257,MNV,\"The **MNV** entity is a medical condition characterized by treatment-na√Øve neovascularization, specifically occurring without any signs of exudation.  It exhibits pachychoroid features, which are specific structural characteristics related to the development and progression of the condition. \n\",11\n417,CLINICAL CHARACTERISTICS,Data regarding patients' clinical and mMNV-related characteristics were collected at baseline,1\n4522,RETINA SPECIALIST,Doctor who diagnoses MNV using multimodal imaging techniques,1\n4804,PCV,Procedure for treatment of MNV,1\n5452,SATTLER'S LAYER,\"The **SATTLER'S LAYER** is a choroidal layer found in the eye.  It is also known as the choroidal layer of the eye. \n\",1\n5455,HALLER'S LAYER,Structure of the eye,1\n1597,OCTA,\"The **OCTA** imaging technique is a specialized tool used to evaluate the eyes. It utilizes optical coherence tomography-angiography (OCTA) to provide detailed images of blood vessels and tissue structure within the eye. This information helps ophthalmologists diagnose and monitor various eye conditions, such as diabetic retinopathy and macular degeneration. \n\",4\n118,PATIENTS,\"The study involved **40 patients** who were diagnosed with various conditions, including **peripheral artery disease**, **acute respiratory distress syndrome (ARDS)**, **critical limb ischemia**, and **prostate cancer**.  These individuals were either participants in the study itself or those already suffering from these conditions. The study included a total of 29 patients. \n\",7\n709,PERIPHERAL ARTERY DISEASE,\"Peripheral artery disease (PAD) is a medical condition that causes blockage of blood flow to the arteries in the limbs. This condition, also known as PAD, affects blood flow to the limbs and poses a challenge to society.  It can be described as a medical condition affecting blood flow to the limbs. \n\",3\n2792,ADSRCS,Adipose-derived regenerative cells used for therapeutic angiogenesis,2\n1789,INFLAMMATORY CHOROIDAL NEOVASCULARIZATION,\"The **inflammatory chorioidal neovascularization** (ICNV) is a condition that causes vision loss.  It involves inflammation of the choroid, which is a layer of tissue behind the retina, leading to neovascularization, or the growth of new blood vessels. \n\",1\n4419,MONTHLY VISITS,,1\n4648,T3 MNV,\"\"\"T3 MNV\"\" refers to **macular neovascularization (MNV)**, a condition that can be classified as a type of **cancer** or a **vision condition**.  It is specifically associated with the **eye**, and often falls under the category of **ocular conditions**. \n\n\n\",6\n3443,FIVE EYES,A group of intelligence agencies,2\n691,EYE,\"The **eye** is a part of the body, specifically the location of the CNV (choroid neovascularization). It is also known as the organ of sight and is where the effects of omega-6 and omega-3 fatty acids are studied.  \n\",1\n4643,GEO,Datasets used to validate the ARG signatures,1\n4660,UNILATERAL EXUDATIVE T3 MNV,Specific type of eye condition,1\n4661,FOLLOW-UP,A period of observation and monitoring after a diagnosis,1\n4521,PACHYCHOROID,\"The **pachychoroi**d is a group of patients characterized by specific structural features in the choroid, a layer of tissue within the eye.  These patients exhibit **choroid structure** anomalies that are often associated with other conditions or diseases. \n\",2\n4523,SENIOR RETINA SPECIALIST,Senior retina specialist using multimodal imaging techniques,3\n4520,ICGA,\"The **ICGA** (Indocyanine Green Angiography) is an imaging technique used to detect multiple neurovascular abnormalities (MNV). Developed by the **ICGA** organization, this method utilizes Indocyanine green as a contrast agent to visualize blood vessels and identify MNV. \n\",3\n4805,PC,Another type of infection that can cause inflammation in the eye,2\n1112,VA,\"The **VA** (Veterans Affairs) is a medical institution that provides healthcare services to veterans.  It is also associated with **VaD**, which stands for Vascular Disease, a condition that impacts the body's circulatory system. \n\",1\n1203,INTERVENTION,Medical treatment for peripheral artery disease,1\n2764,LIMB ISCHEMIA,A condition where blood flow to limbs is restricted,1\n2932,EXUDATION,\"**Exudation** is the process of fluid buildup in the eye. This can manifest as a condition known as **eye effusion**, where excess fluids accumulate within the eye, potentially leading to vision impairment. \n\",2\n2794,TACT,,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n2070,BROLUCIZUMAB,MNV,Brolucizumab is a medication used to treat MNV-related inflammation,14\n211,MNV,CLINICAL CHARACTERISTICS,MNV may be associated with clinical characteristics of affected eyes,12\n1908,RETINA SPECIALIST,MNV,Senior retina specialist diagnosed MNV using multimodal imaging techniques,12\n2069,MNV,PCV,The study compares the effect of Brolucizumab on MNV with the standard PCV procedure,12\n2349,MNV,SATTLER'S LAYER,The ratio of Sattler's layer area to total choroidal area changes according to the disease activity,12\n2350,MNV,HALLER'S LAYER,The development and progression of MNV is related to a change in the choroidal interlayer area ratio following the relatively larger dilation of Haller's layer vessels,12\n594,OCTA,PATIENTS,Used to evaluate patients' eyes,11\n423,PERIPHERAL ARTERY DISEASE,PATIENTS,Peripheral artery disease is a condition that affects patients,10\n1105,PATIENTS,ADSRCS,Patients with limb ischemia are being treated with ADRCs for therapeutic angiogenesis,9\n1826,INFLAMMATORY CHOROIDAL NEOVASCULARIZATION,PATIENTS,Patients with inflammatory CNV were included in the study,8\n1829,PATIENTS,MONTHLY VISITS,Patients were seen monthly for treatment,8\n1980,T3 MNV,FIVE EYES,Five eyes developed active exudative T3 MNV after 23 months,8\n1987,PATIENTS,EYE,Patients with eye conditions are diagnosed by an eye doctor,8\n1981,T3 MNV,GEO,T3 MNV was studied in five eyes,7\n1985,T3 MNV,UNILATERAL EXUDATIVE T3 MNV,T3 MNV is a precursor to unilateral exudative T3 MNV,7\n1986,T3 MNV,FOLLOW-UP,T3 MNV can be followed up on for 3 years,7\n1904,OCTA,PACHYCHOROID,\"Patients with pachychoroid characteristics were recruited for OCTA and ICGA imaging\nPatients with pachychoroid characteristics who had undergone OCTA imaging at the same visit\",6\n1909,SENIOR RETINA SPECIALIST,ICGA,Senior retina specialist reviewed ICGA images for MNV detection,6\n1906,ICGA,PACHYCHOROID,Patients with pachychoroid characteristics who had undergone ICGA imaging at the same visit,5\n2071,BROLUCIZUMAB,PC,Brolucizumab is a medication used to treat PC-related inflammation,5\n371,VA,BROLUCIZUMAB,VA used brolucizumab as part of their treatment plan,4\n424,PERIPHERAL ARTERY DISEASE,INTERVENTION,Intervention is a medical treatment for peripheral artery disease,4\n1341,LIMB ISCHEMIA,PERIPHERAL ARTERY DISEASE,Limb ischemia is a manifestation of peripheral artery disease,4\n1983,FIVE EYES,EXUDATION,Five eyes showed exudation over 3 years of follow-up,4\n1106,ADSRCS,TACT,Therapeutic angiogenesis using cell transplantation of ADRCs,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_c91ce01fb7efce88a4e26593522e1cbdfda521ab3ded200e70fc3574faed5fe2_v2"}